{
"@context": "/terms/",
"@id": "/human-beta-cell-line/PKBSM0561GQKP/",
"@type": [
"HumanBetaCellLines",
"Biosample",
"Sample",
"Item"
],
"accession": "PKBSM0561GQKP",
"age": "unknown",
"aliases": [
"pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816"
],
"audit": {
"INTERNAL_ACTION": [
{
"category": "mismatched status",
"detail": "Released human beta cell lines [PKBSM0561GQKP](/human-beta-cell-line/PKBSM0561GQKP/) has in progress subobject sample term [CVCL_IS72](/sample-terms/CVCL_IS72/).",
"level": 30,
"level_name": "INTERNAL_ACTION",
"name": "audit_item_status",
"path": "/human-beta-cell-line/PKBSM0561GQKP/"
}
],
"WARNING": [
{
"category": "incorrect classifications format",
"detail": "Human beta cell line [PKBSM0561GQKP](/human-beta-cell-line/PKBSM0561GQKP/) has `classifications` ['human beta cell line'] but should be [\"cell line\"]. Human beta cell lines are expected to have classifications as an array.",
"level": 40,
"level_name": "WARNING",
"name": "audit_classifications_format_check",
"path": "/human-beta-cell-line/PKBSM0561GQKP/"
}
]
},
"award": {
"@id": "/awards/U24DK138512-DK138515/",
"component": "data coordination"
},
"classifications": [
"human beta cell line"
],
"coating_condition": "ECM, fibronectin",
"creation_timestamp": "2025-10-21T21:46:35.747579+00:00",
"description": "EndoC-bH3 cells treated with 4-hydroxy tamoxifen for three weeks from GSE207816",
"donors": [
{
"@id": "/human-donors/PKBDO8293TLPA/",
"accession": "PKBDO8293TLPA",
"age": 0,
"summary": "PKBDO8293TLPA",
"taxa": "Homo sapiens"
}
],
"excision_status": "excised",
"file_sets": [
{
"@id": "/analysis-sets/PKBDS6778XLCV/",
"accession": "PKBDS6778XLCV",
"aliases": [
"pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816_AnalysisSet"
],
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "intermediate analysis of RNA-seq data"
},
{
"@id": "/measurement-sets/PKBDS0486ONFQ/",
"accession": "PKBDS0486ONFQ",
"aliases": [
"pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816_MeasurementSet"
],
"assay_term": {
"term_name": "bulk RNA-seq assay"
},
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "bulk RNA-seq assay (RNA-seq)"
}
],
"growth_medium": "DMEM low glucose (1 g/L) supplemented with 2% fatty acid free BSA , 10 mM nicotinamide, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite, 50 µM β-mercaptoethanol, 100 U/mL penicillin and 100 µg/mL streptomycin",
"institutional_certificates": [],
"lab": {
"@id": "/labs/pankbase-consortium/",
"title": "Pankbase Consortium, PanKbase"
},
"multiplexed_in": [],
"origin_of": [],
"parts": [],
"pooled_in": [],
"publication_identifiers": [
"PMID:38682582"
],
"release_timestamp": "2025-10-27T19:40:52.477647+00:00",
"sample_name": "EndoC-bH3",
"sample_terms": [
{
"@id": "/sample-terms/CVCL_IS72/",
"term_name": "EndoC-bH3"
}
],
"sorted_fractions": [],
"status": "released",
"submitted_by": {
"@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
"title": "Ying Sun"
},
"summary": "EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days",
"taxa": "Homo sapiens",
"treatments": [
{
"@id": "/treatments/8741ffa1-584b-4e39-8137-f3b67145ec9d/",
"purpose": "activation",
"status": "released",
"summary": "Treatment of 1 mM 4-hydroxy tamoxifen for 21 days",
"treatment_type": "chemical"
}
],
"uuid": "f084aa15-7786-4443-ae29-b3180964b313",
"virtual": false
}